Rapidly polymerized composition and application thereof

Through the combination of liquid 3-methacryloyloxysulfolane and sulfur dioxide gas, the rapid polymerization and curing of methacrylate monomers is achieved, which solves the problem of slow polymerization speed, provides colorless and transparent medical glue and suitable for 3D Printed materials with good biocompatibility and anti-adsorption properties.

CN119080981APending Publication Date: 2024-12-06JIANGSU UNIV OF TECH
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411332347.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The current methacrylate monomers are slow to polymerize and cure, which limits their application in the fields of medical adhesives and 3D printing.

Method used

The liquid 3-methacryloyloxysulfolane polymerized monomer containing sulfolane and sulfur dioxide-containing gas were combined to perform rapid polymerization through a free radical mechanism, and the polymerization temperature was controlled at 0-40°C and the polymerization time was less than 1 minute.

Benefits of technology

It realizes rapid polymerization and curing, the polymer is colorless and transparent, avoids whitening, is suitable for ophthalmic applications, and has good biocompatibility and non-specific protein adsorption properties, which is suitable for 3D printing of bioactive materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080981A_ABST
    Figure CN119080981A_ABST
Patent Text Reader

Abstract

The invention discloses a rapidly polymerized composition and application thereof. The composition comprises a liquid polymeric monomer containing 3-methacryloyloxy sulfolane and a gas containing sulfur dioxide. The method for preparing the medical adhesive or the 3D printing object by using the composition comprises the following steps: (1) distributing a liquid polymeric monomer containing 3-methacryloyloxy sulfolane under the condition of 0-60 DEG C; and (2) exposing the distributed polymeric monomer containing 3-methacryloyloxy sulfolane to gas containing sulfur dioxide for curing. According to the rapid polymerization method of 3-methacryloyloxy sulfolane, provided by the invention, the polymerization speed is very high, no induction period exists, the polymerization-curing time is less than 1 min, and the optimized polymerization-curing time is less than 10 s.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a methacrylate monomer polymerization system and application thereof, and in particular to a rapid polymerization composition based on 3-methacryloyloxy sulfolane and application thereof. Background Art

[0002] The rapid polymerization method of polymerizable monomers has important applications. For example, α-cyanoacrylate can rapidly undergo anionic polymerization under the action of water, alcohol, etc., and complete curing within a few minutes or even seconds. It can be used as an instant adhesive and applied in the field of medical adhesives; however, such adhesives easily form a layer of white film on the bonded surface, also known as whitening, which limits its application field. A Chinese patent (application number 202080019948.5) discloses a method for extending the application of rapid polymerization of cyanoacrylate to the field of 3D printing. However, these rapid polymerization methods are only applicable to cyanoacrylate monomers. 3D printing based on photocuring also relies on the rapid polymerization of photosensitive resin monomers. For example, a decrease in the polymerization-curing speed of photosensitive resins will cause a decrease in the geometric accuracy and molding efficiency of the parts, or even make 3D printing impossible; due to the poor curing performance of the shadow area during the curing process, the toxicity, compatibility, and biodegradability of the raw materials, etc., the further application of such 3D printing technology in biomedicine and other fields is limited.

[0003] Literature (Journal of Macromolecular Science: Part A-Chemistry, 1967, 1: 1393–1405.) reported that gaseous sulfur dioxide (SO2) can directly initiate the free radical polymerization of methyl methacrylate, ethyl methacrylate, and butyl methacrylate; if a SO2-tert-butyl hydroperoxide initiation system is used, the polymerization rate can be increased, but it also takes minutes to achieve a high conversion rate, and it is impossible to achieve a rapid polymerization-curing process of less than 1 minute, which limits the application of this polymerization system in the fields of medical adhesives and 3D printing.

[0004] 3-Methacryloyloxysulfolane, also known as methacrylate sulfolane, is a methacrylate polymerizable monomer. The sulfolane structure in the monomer can form a zwitterionic structure, and such compounds have good biocompatibility and resistance to nonspecific protein adsorption. The literature (Langmuir 2016, 32, 765-771) reported that the RAFT polymerization method of the monomer required a reaction at 60°C for 24 hours, showing a low reaction rate and a high reaction temperature, and could not achieve rapid polymerization-curing at a lower temperature similar to α-cyanoacrylate or photosensitive resin, which limited the application of the monomer in medical adhesives and 3D printing through the RAFT polymerization-curing method. Summary of the invention

[0005] Purpose of the invention: The purpose of the present invention is to provide a fast-polymerizing composition to solve the problem of slow polymerization and curing speed of existing methacrylate monomers. Another purpose of the present invention is to propose an application of a fast-polymerizing composition in the preparation of medical glue or 3D printed objects to solve the problem of how to quickly cure and prepare objects.

[0006] Technical solution: The fast polymerization composition of the present invention comprises a liquid polymerization monomer containing 3-methacryloyloxy cyclopentane sulfone and a gas containing sulfur dioxide.

[0007] Preferably, the polymerizable monomer is a pure 3-methacryloyloxy sulfolane monomer without free radical inhibitors and / or retarders; the gas containing sulfur dioxide is a mixed gas of SO2 and a carrier gas in a volume ratio of 1:0 to 4, and the carrier gas is an inert gas or air. The inert gas can be selected from nitrogen, argon, helium and other gases, and is mainly used as a carrier gas for SO2. Free radical inhibitors and / or retarders include hydroquinone, p-methoxyphenol and the like.

[0008] Preferably, the polymerizable monomers further include at least one of free radical polymerizable monomers, diluents, stabilizers, promoters, plasticizers, toughening agents, fillers, opacifiers, thickeners, viscosity modifiers, inhibitors, thixotropy imparting agents, dyes, pigments, and fluorescent markers.

[0009] Preferably, the free radical polymerizable monomers include methyl methacrylate, ethyl methacrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, isopropyl methacrylate, allyl methacrylate, 2-hydroxypropyl methacrylate, 2-ethoxyethyl methacrylate, methoxyethyl methacrylate, butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate, hexyl methacrylate, cyclohexyl methacrylate, octyl methacrylate, 2-ethylhexyl methacrylate, 6-methylheptyl methacrylate, isodecyl methacrylate, lauryl methacrylate, octadecyl methacrylate, isobornyl methacrylate, mevalonolactone methacrylate, N-succinimidyl methacrylate, 2,2,3,3-tetrafluoropropyl methacrylate, trifluoroethyl methacrylate. , hexafluorobutyl methacrylate, 2-(perfluorobutyl)ethyl methacrylate, 2-(perfluorooctyl)ethyl methacrylate, dodecafluoroheptyl methacrylate, triisopropyl methacrylate, trimethylsilyl methacrylate, 2-(trimethylsiloxy)ethyl methacrylate, (methacryloyloxymethyl)methyldiethoxysilane, 3-(ethoxydimethylsilyl)propyl methacrylate, 3-(triethoxysilyl)propyl methacrylate, 3-(dimethoxy(methyl)silyl)propyl methacrylate, 3-(diethoxy(methyl)silyl)propyl methacrylate, 1,4-butanediol dimethacrylate, 1,3-butanediol dimethacrylate, neopentyl glycol dimethacrylate, nonanediol dimethacrylate, and at least one of trimethylolpropane trimethacrylate.

[0010] The present invention further uses the above-mentioned fast-polymerizing composition in the preparation of medical glue or 3D printed objects.

[0011] The specific method of the above application includes the following steps:

[0012] (1) distributing a liquid polymerizing monomer containing 3-methacryloyloxy sulfolane at a temperature of 0 to 60° C.;

[0013] (2) The distributed 3-methacryloyloxy sulfolane-containing polymerized monomer is exposed to a gas containing sulfur dioxide for curing.

[0014] The aggregation process is as follows:

[0015]

[0016] In some embodiments, the polymerization temperature is preferably 0-40° C. Steps (1) and (2) are repeated at least once to form a three-dimensional object.

[0017] In the above polymerization reaction, the raw material 3-methacryloxy sulfolane should not contain a free radical inhibitor and should be kept in a liquid state before the introduction of SO2. 3-methacryloxy sulfolane is polymerized in the form of a pure monomer or a composition, SO2 is provided in the form of pure SO2 gas or a carrier gas containing SO2, wherein SO2 is an initiator, and the polymerization reaction is carried out through a free radical mechanism.

[0018] It should be pointed out that, as disclosed in the patent (application number: 202311012295.X), the purity of 3-methacryloxy sulfolane in liquid form will decrease during storage. The impurities generated by this purity decrease may cause the polymerization method of the present invention to fail to achieve the desired effect. Therefore, pure 3-methacryloxy sulfolane is best stored in a solid state, and the storage temperature is usually below 4°C. At this time, 3-methacryloxy sulfolane has good storage stability. This high-purity, solid-state 3-methacryloxy sulfolane, which does not contain inhibitors and retarders, can be obtained by recrystallization. If high-purity 3-methacryloyloxy sulfolane solid is used as the raw material, since the melting point of 3-methacryloyloxy sulfolane is 39-40° C., when the polymerization reaction is carried out below the melting point, in order to ensure that 3-methacryloyloxy sulfolane is liquid, the 3-methacryloyloxy sulfolane solid should be heated to be completely melted and then cooled to the polymerization reaction temperature. At this time, although the 3-methacryloyloxy sulfolane is below the melting point, it can be in a supercooled liquid state with good fluidity for at least 10 hours thereafter.

[0019] The raw materials in the above-mentioned polymerization reaction can also be polymerized in the form of a 3-methacryloyloxy sulfolane composition. The composition is used in liquid form and can be obtained by heating and melting solid 3-methacryloyloxy sulfolane, cooling it to the polymerization reaction temperature, and adding one or more selected additives. It should be pointed out that there should be no free radical inhibitors and retarders remaining in the additives. When the additive is a free radical polymerizable monomer, such free radical polymerizable monomer will participate in the polymerization in the form of copolymerization; such commercial free radical polymerizable monomers usually contain free radical inhibitors and / or retarders, such as p-methoxyphenol, which need to be strictly removed by purification methods known in the art such as water washing, distillation and / or column chromatography before use.

[0020] Preferably, in step (1), the method for preparing the polymerizable monomer containing 3-methacryloyloxy sulfolane comprises the following steps:

[0021] (11) Using 3-cyclobutane sulfone as a raw material to prepare 3-hydroxycyclobutane sulfone;

[0022] (12) using 3-hydroxysulfolane and methacryloyl chloride as raw materials to prepare crude 3-methacryloyloxysulfolane;

[0023] (13) The crude 3-methacryloxy sulfolane product is recrystallized using a solvent to ensure that the recrystallized product does not contain a free radical inhibitor and / or a retarder, thereby obtaining a pure 3-methacryloxy sulfolane monomer.

[0024] Preferably, in step (13), the solvent is a mixed solvent of petroleum ether and tetrahydrofuran or a mixed solvent of methanol and water, and the recrystallization temperature is -10 to -30°C.

[0025] Preferably, in step (1), the dispensing method is to use a 3D printer to dispense the liquid polymerizable monomer onto the building surface of a print pad.

[0026] In some embodiments, the 3D printer is selected from a fused deposition modeling (FDM) 3D printer, a direct ink writing (DIW) 3D printer, or a 3D inkjet printer.

[0027] Preferably, in step (2), the method of exposing to a gas containing sulfur dioxide is:

[0028] (i) directing a gas containing sulphur dioxide in the form of a gas stream continuously or intermittently onto the distributed material, and / or

[0029] (ii) continuously or intermittently filling at least the interior volume of a housing surrounding a dispensing unit of the 3D printer with a gas containing sulfur dioxide.

[0030] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:

[0031] The rapid polymerization method of 3-methacryloyloxy cyclopentane sulfone provided by the present invention has a very rapid polymerization speed, no induction period, a polymerization-curing time of less than 1 minute, and an optimized polymerization-curing time of less than 10 seconds. The two-component medical glue based on the rapid polymerization method of 3-methacryloyloxy cyclopentane sulfone provided by the present invention has a colorless and transparent cured product without whitening, which is beneficial for ophthalmic applications. The method for preparing three-dimensional objects based on the rapid polymerization of 3-methacryloyloxy cyclopentane sulfone provided by the present invention has a mild polymerization-curing temperature that can be achieved at 0 to 40°C; it can avoid the introduction of toxic photosensitizers required for light-curing 3D printing technology; the polymer has a cyclopentane sulfone structure, has good biocompatibility, anti-nonspecific protein adsorption and other properties, which is beneficial for 3D printing of bioactive materials and 3D printing applications in the human body. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 is the infrared spectrum (total reflection infrared spectroscopy) of the polymer obtained in Example 1;

[0033] Figure 2 This is a picture of the colorless and transparent polymer obtained in Example 1;

[0034] Figure 3 This is a schematic diagram of the method for using the two-component medical adhesive in Example 6;

[0035] Figure 4 This is a schematic diagram of 3D printing using a DIW type 3D printer in Example 7. DETAILED DESCRIPTION

[0036] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.

[0037] Unless otherwise specified, the materials, reagents, etc. used in the embodiments of the present invention can be obtained from commercial sources.

[0038] Example 1: A fast polymerizing composition comprising a liquid polymerizable monomer containing 3-methacryloyloxy sulfolane and pure sulfur dioxide gas.

[0039] The preparation method of the liquid polymerizable monomer containing 3-methacryloyloxy sulfolane is as follows:

[0040] (1) 250.0 g of 3-cyclobutane sulfone was dissolved in 530.0 mL of 2 mol / L sodium hydroxide aqueous solution. The mixture was reacted at room temperature under stirring for 24 hours. Then about 88.5 mL of 12 mol / L hydrochloric acid was slowly added to adjust the pH of the reaction solution to 6.5-7.0. After the obtained mixture was dehydrated under reduced pressure at 80-90° C., 300 mL of acetone was added to the concentrated solution, and the salt was filtered off. The filtrate was desolvated under reduced pressure at 40° C. The obtained 3-hydroxycyclobutane crude product was kept at 155° C. for 2 hours, and then under reduced pressure distillation was carried out at 200° C. to obtain a purified 3-hydroxycyclobutane product with a yield of 82% and a GC (gas chromatography) purity of 99.0%.

[0041] (2) 110.0 g of 3-hydroxycyclopentane sulfolane was dissolved in a mixture of 500 mL of anhydrous dichloromethane and 225 mL of anhydrous triethylamine and cooled to 0°C. Under nitrogen protection, 92.8 g of methacryloyl chloride was added dropwise to the solution within 60 min and the reaction mixture temperature was kept at 0°C during the reaction. After the addition was completed, the reaction was continued at 0°C for 30 min. Subsequently, the reaction mixture was heated to room temperature and reacted for 60 min. The reaction solution was quenched with 300 mL of saturated sodium bicarbonate aqueous solution, separated, and the organic phase was washed with saturated brine, dried over anhydrous magnesium chloride, and concentrated under reduced pressure. The obtained product was purified by silica gel column chromatography (tetrahydrofuran: petroleum ether = 1:4, v / v) to obtain a pale yellow oily 3-methacryloyloxycyclopentane crude product with a yield of 83% and a GC purity of 95.3%.

[0042] (3) 18.5 g of crude 3-methacryloyloxy sulfolane was recrystallized from a mixed solvent of petroleum ether (80 mL) and tetrahydrofuran (40 mL) at -20°C. The resulting solid was dried at 0°C to constant weight to obtain 16.1 g of a white powder solid with a GC purity of 99.2%. The impurities did not contain free radical inhibitors such as hydroquinone and p-methoxyphenol, i.e., pure 3-methacryloyloxy sulfolane monomer.

[0043] The above composition is used to prepare medical glue or 3D printed objects, and the curing method is as follows:

[0044] The pure 3-methacryloxy sulfolane monomer (5.0 g) prepared by the above method was heated and melted, and then cooled to room temperature (20° C.), at which time, the 3-methacryloxy sulfolane remained in a liquid state. SO2 gas flow was introduced into the above liquid 3-methacryloxy sulfolane for bubbling, and within 10 seconds (the time from the introduction of SO2 to the SO2 gas stopping rising in the reaction system), the above 3-methacryloxy sulfolane liquid was polymerized and solidified into a colorless transparent polymer solid.

[0045] Embodiment 2: The rest is the same as Embodiment 1, except that:

[0046] 18.5 g of crude 3-methacryloyloxy sulfolane was recrystallized from a mixed solvent of methanol (80 mL) and water (80 mL) at -20°C to obtain 16.0 g of white powder solid with GC purity = 99.0%. Impurities did not contain free radical inhibitors such as hydroquinone and p-methoxyphenol.

[0047] Embodiment 3: The rest is the same as Embodiment 1, except that:

[0048] Pure 3-methacryloxy sulfolane monomer (3.0 g) was heated and melted, and then cooled to room temperature (25°C). A carrier gas containing SO2 (volume ratio of SO2 to nitrogen was 1:1) was introduced into the liquid 3-methacryloxy sulfolane at a flow rate of 10 mL / min, and the 3-methacryloxy sulfolane liquid solidified into a colorless and transparent polymer within 12 seconds.

[0049] Embodiment 4: The rest is the same as Embodiment 1, except that:

[0050] Pure 3-methacryloxy sulfolane monomer (5.0 g) was heated and melted, then cooled to 36° C., and 0.5 g of freshly distilled methyl methacrylate was added. SO2 gas was bubbled into the liquid 3-methacryloxy sulfolane composition, and the 3-methacryloxy sulfolane composition solidified into a colorless transparent polymer solid within 15 seconds.

[0051] Embodiment 5: The rest is the same as Embodiment 1, except that:

[0052] The pure 3-methacryloxy sulfolane monomer (2.0 g) prepared in Example 2 was heated to melt and then cooled to room temperature to obtain a two-component medical adhesive component 1. The component 1 was drawn into the syringe using a 10 mL syringe and about 2 mL of SO2 gas (component 2) was drawn into the syringe and mixed with the component 1 quickly and injected and coated onto the bleeding site. After solidification, it can play a role of bonding and sealing.

[0053] Example 6: According to Figure 3 Schematic diagram of the use method of two-component medical adhesive, the pure 3-methacryloxy sulfolane monomer (2.0g) prepared in Example 1 is heated to melt and then cooled to room temperature to obtain two-component medical adhesive component 1. After the component 1 is applied to the part to be coated, the opening side of the gas hood with an inlet duct and an outlet duct is placed above the coating part and the edge of the gas hood opening is in continuous and close contact with the coating part to form a closed space, and the inlet duct is passed through a carrier gas flow containing sulfur dioxide (component 2, SO2 and nitrogen volume ratio is 1:1, flow rate 10mL / min) for 15s, and then the inlet duct is passed through a nitrogen flow for 1min (flow rate 30mL / min), and the medical adhesive to be coated can play a bonding and sealing role after solidification.

[0054] Example 7: According to Figure 4 Schematic diagram of 3D printing using a DIW type 3D printer. The pure 3-methacryloxy sulfolane monomer (10.0 g) prepared in Example 2 is heated and melted and then cooled to room temperature. The obtained liquid 3-methacryloxy sulfolane is added to the DIW type 3D printer as ink, and the printing pad and the printed three-dimensional object are placed in an SO2 atmosphere. Figure 4 The range indicated by the dotted box is SO2 atmosphere, where 3D printing can be performed.

[0055] Embodiment 8: The rest is the same as Embodiment 1, except that:

[0056] Pure 3-methacryloxy sulfolane monomer (3.0 g) was heated and melted, and then cooled to room temperature (25°C). A carrier gas containing SO2 (volume ratio of SO2 to air was 1:1) was introduced into the liquid 3-methacryloxy sulfolane at a flow rate of 10 mL / min, and the 3-methacryloxy sulfolane liquid solidified into a colorless and transparent polymer within 15 seconds.

[0057] Comparative Example 1: The rest is the same as Example 1, except that:

[0058] The pure 3-methacryloxysulfolane monomer was replaced with methyl methacrylate.

[0059] No curing was observed within 5 minutes after SO2 was introduced into methyl methacrylate.

[0060] Comparative Example 2: The rest is the same as Example 1, except that:

[0061] The pure 3-methacryloxysulfolane monomer was replaced with ethyl methacrylate.

[0062] No curing was observed within 5 minutes after SO2 was introduced into ethyl methacrylate.

[0063] Comparative Example 3: The rest is the same as Example 1, except that:

[0064] The pure 3-methacryloxysulfolane monomer was replaced with butyl methacrylate.

[0065] No curing was observed within 5 minutes after SO2 was introduced into butyl methacrylate.

[0066] By comparing the polymerization and curing time of Example 1 with that of Comparative Examples 1-3, it can be seen that sulfur dioxide, as an auxiliary initiator, takes a long time to polymerize methacrylate monomers in the absence of a main initiator, and cannot meet the rapid curing requirements of manufacturing methods such as 3D printing. Only when 3-methacryloyloxy cyclopentane sulfone monomer is used in combination with SO2, can it be rapidly polymerized and cured in no more than 15 seconds, which can be successfully applied to various scenarios requiring rapid curing.

Claims

1. A fast polymerizing composition, characterized in that: The invention comprises liquid polymerization monomer containing 3-methacryloyloxy cyclopentane sulfone and gas containing sulfur dioxide.

2. A fast polymerizing composition according to claim 1, characterized in that: The polymerizable monomer is a pure 3-methacryloyloxy sulfolane monomer without free radical inhibitor and / or retarder; the gas containing sulfur dioxide is a mixed gas of SO2 and carrier gas in a volume ratio of 1:0-4, and the carrier gas is an inert gas or air.

3. A fast polymerizing composition according to claim 1, characterized in that: The polymerizable monomers also include at least one of free radical polymerizable monomers, diluents, stabilizers, promoters, plasticizers, tougheners, fillers, opacifiers, thickeners, viscosity modifiers, inhibitors, thixotropy imparting agents, dyes, pigments, and fluorescent markers.

4. A fast polymerizing composition according to claim 3, characterized in that: The free radical polymerizable monomers include methyl methacrylate, ethyl methacrylate, hydroxyethyl methacrylate, hydroxypropyl methacrylate, isopropyl methacrylate, allyl methacrylate, 2-hydroxypropyl methacrylate, 2-ethoxyethyl methacrylate, methoxyethyl methacrylate, butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate, hexyl methacrylate, cyclohexyl methacrylate, octyl methacrylate, 2-ethylhexyl methacrylate, 6-methylheptyl methacrylate, isodecyl methacrylate, lauryl methacrylate, octadecyl methacrylate, isobornyl methacrylate, mevalonolactone methacrylate, N-succinimidyl methacrylate, 2,2,3,3-tetrafluoropropyl methacrylate, trifluoroethyl methacrylate, methyl At least one of hexafluorobutyl acrylate, 2-(perfluorobutyl)ethyl methacrylate, 2-(perfluorooctyl)ethyl methacrylate, dodecafluoroheptyl methacrylate, triisopropyl methacrylate, trimethylsilyl methacrylate, 2-(trimethylsiloxy)ethyl methacrylate, (methacryloyloxymethyl)methyldiethoxysilane, 3-(ethoxydimethylsilyl)propyl methacrylate, 3-(triethoxysilyl)propyl methacrylate, 3-(dimethoxy(methyl)silyl)propyl methacrylate, 3-(diethoxy(methyl)silyl)propyl methacrylate, 1,4-butylene glycol dimethacrylate, 1,3-butylene glycol dimethacrylate, neopentyl glycol dimethacrylate, nonanediol dimethacrylate, and trimethylolpropane trimethacrylate.

5. Use of the rapidly polymerizing composition according to any one of claims 1 to 4 in the preparation of medical glue or 3D printed objects.

6. The use according to claim 5, characterized in that The steps include: (1) distributing a liquid polymerizing monomer containing 3-methacryloyloxy sulfolane at a temperature of 0 to 60° C.; (2) The distributed 3-methacryloyloxy sulfolane-containing polymerized monomer is exposed to a gas containing sulfur dioxide for curing.

7. The use according to claim 6, characterized in that: In step (1), the method for preparing the polymerizable monomer containing 3-methacryloyloxy sulfolane comprises the following steps: (11) Using 3-cyclobutane sulfone as a raw material to prepare 3-hydroxycyclobutane sulfone; (12) using 3-hydroxysulfolane and methacryloyl chloride as raw materials to prepare crude 3-methacryloyloxysulfolane; (13) The crude 3-methacryloxy sulfolane product is recrystallized using a solvent to ensure that the recrystallized product does not contain a free radical inhibitor and / or a retarder, thereby obtaining a pure 3-methacryloxy sulfolane monomer.

8. The use according to claim 7, characterized in that: In step (13), the solvent is a mixed solvent of petroleum ether and tetrahydrofuran or a mixed solvent of methanol and water, and the recrystallization temperature is -10 to -30°C.

9. The use according to claim 6, characterized in that: In step (1), the dispensing method is to use a 3D printer to dispense the liquid polymerizable monomer onto the building surface of a print pad.

10. The use according to claim 6, characterized in that: In step (2), the method of exposing to a gas containing sulfur dioxide is: (i) directing a gas containing sulphur dioxide in the form of a gas stream continuously or intermittently onto the distributed material, and / or (ii) continuously or intermittently filling at least the interior volume of a housing surrounding a dispensing unit of the 3D printer with a gas containing sulfur dioxide.

Citation Information

Patent Citations

  • Gas activated cyanoacrylates for 3D printing

    CN115943072A

  • Preparation method and application of additive for reducing polymerization heat of alpha-cyanoacrylate medical adhesive

    CN117024402A